AdaptHealth says it continues to make progress
By HME News Staff
Updated 10:00 AM CST, Tue February 25, 2025
PLYMOUTH MEETING, Pa. - AdaptHealth has reported net revenue of $856.6 million for the fourth quarter of 2024, a 0.2% decrease compared to the same period in 2023, and $3.26 billion for the full year 2024, a 1.9% increase compared to 2023.
Net income was $50.3 million vs. a net loss of $254.5 million for the quarter and $90.4 million vs. a net loss of $678.9 million for the year.
“Over the course of the second half of 2024, we continued to make progress on our five areas of focus, which include our One Adapt initiative, accelerating the application of AI and automation, increasing our clinical relevance, delivering organic growth and strengthening our balance sheet,” said Suzanne Foster, CEO. “The progress we have made helped drive our solid fourth quarter results and, more importantly, is strengthening our foundation for long-term success and growth.”
AdaptHealth reported adjusted EBITDA of $200.6 million for the quarter, a 2% decrease, and $688.7 million for the year, a 2.7% increase.
For fiscal year 2025, the company expects net revenue of $3.22 billion to $3.36 billion; adjusted EBITDA of $670 million to $710 million; and free cash flow of $180 million to $220 million.
Comments